Dr Ford Brewer - PrevMed Warning! Seniors, This 1 Habit Enlarges your Prostate Everyday - Ford Brewer MD MPH (PrevMed Health)
7 snips
Sep 21, 2025 In this engaging discussion, health coach Jesus shares insights on metabolic drivers of prostate enlargement. He and Dr. Brewer highlight how insulin and IGF contribute to benign prostate hyperplasia and explain why common medications might fall short. They dive into the impact of refined carbohydrates on insulin resistance, shedding light on everyday habits that can worsen prostate health. The conversation also touches on essential screening practices and the significance of maintaining muscle health in older adults.
AI Snips
Chapters
Transcript
Episode notes
Insulin Is A Primary Driver Of Prostate Growth
- High insulin and IGF are major drivers of benign prostate hyperplasia by stimulating prostate cell proliferation and inflammation.
- Insulin also lowers SHBG and increases DHT production inside the prostate, promoting growth.
Blocking DHT Alone Misses Key Mechanisms
- Finasteride blocks 5-alpha reductase to reduce DHT but does not affect insulin resistance or the other growth pathways.
- Treating only DHT ignores insulin and visceral-fat/estrogen mechanisms that also enlarge the prostate.
Visceral Fat Links Insulin To Estrogen And Growth
- Visceral fat converts testosterone to estrogen via aromatase, and elevated estrogen can stimulate prostate growth.
- Insulin-driven visceral fat therefore contributes to prostate hyperplasia through hormonal and inflammatory pathways.